The Clinical Scholars Biomedical Research Training Program at Memorial Sloan-Kettering Cancer Center (MSKCC) provides a mentored laboratory training experience in cancer research for a group of outstanding MD's or MD/PhD's. This training will prepare highly qualified physician-scientists for a career at the interface of cancer biology and clinical research. Six positions are requested. The fellows are trained by principal investigators, drawn from the professional staff of Memorial Sloan-Kettering Cancer Center who are laboratory investigators. A structured and cohesive two-year training program has been designed to provide outstanding mentorship in guided laboratory research, didactic course work in modern biology and bioinformatics and career development skills. Trainees have access to all resources of the Memorial Sloan-Kettering Cancer Center. The areas of principal emphasis for research include: 1) Signals and pathways involved in control of cell proliferation;2) Regulatory pathways involved in developmental biology and cell differentiation;3) Cell-cell interactions, adhesion and protein targeting;4) Tumor immunology, immunotherapy and transplantation biology;5) Human cancer biology, mouse models of cancer, genetics and molecular pathology;and 6) Drug development and therapeutics. Physicians-scientists receiving training from this program will be poised to more readily translate the recent revolutionary discoveries of biomedical, cancer-related research into patient care.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
5T32CA009512-26
Application #
8299403
Study Section
Subcommittee G - Education (NCI)
Program Officer
Lim, Susan E
Project Start
1985-02-01
Project End
2015-06-30
Budget Start
2012-07-01
Budget End
2013-06-30
Support Year
26
Fiscal Year
2012
Total Cost
$232,458
Indirect Cost
$20,170
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Callahan, Margaret K; Masters, Gregg; Pratilas, Christine A et al. (2014) Paradoxical activation of T cells via augmented ERK signaling mediated by a RAF inhibitor. Cancer Immunol Res 2:70-9
Snyder, Alexandra; Makarov, Vladimir; Merghoub, Taha et al. (2014) Genetic basis for clinical response to CTLA-4 blockade in melanoma. N Engl J Med 371:2189-99
Rizzuto, Gabrielle A; Merghoub, Taha; Hirschhorn-Cymerman, Daniel et al. (2009) Self-antigen-specific CD8+ T cell precursor frequency determines the quality of the antitumor immune response. J Exp Med 206:849-66
Marcucci, Guido; Maharry, Kati; Radmacher, Michael D et al. (2008) Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a Cancer and Leukemia Group B Study. J Clin Oncol 26:5078-87
Perales, M-A; Ishill, N; Lomazow, W A et al. (2007) Long-term follow-up of patients treated with daclizumab for steroid-refractory acute graft-vs-host disease. Bone Marrow Transplant 40:481-6
Marcucci, Guido; Maharry, Kati; Whitman, Susan P et al. (2007) High expression levels of the ETS-related gene, ERG, predict adverse outcome and improve molecular risk-based classification of cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B Study. J Clin Oncol 25:3337-43
Lassman, Andrew B; Abrey, Lauren E; Shah, Gaurav D et al. (2006) Systemic high-dose intravenous methotrexate for central nervous system metastases. J Neurooncol 78:255-60
Perales, Miguel-Angel; Diab, Adi; Cohen, Adam D et al. (2006) DNA immunization against tissue-restricted antigens enhances tumor immunity after allogeneic hemopoietic stem cell transplantation. J Immunol 177:4159-67
Weinstock, David M; Elliott, Beth; Jasin, Maria (2006) A model of oncogenic rearrangements: differences between chromosomal translocation mechanisms and simple double-strand break repair. Blood 107:777-80
Radmacher, Michael D; Marcucci, Guido; Ruppert, Amy S et al. (2006) Independent confirmation of a prognostic gene-expression signature in adult acute myeloid leukemia with a normal karyotype: a Cancer and Leukemia Group B study. Blood 108:1677-83

Showing the most recent 10 out of 110 publications